CLINICAL_TRIALS
research
· 2007-10-10
Clinical Trial Update: Ephedrine for the Treatment of Congenital Myasthenia [Phase 1, Phase 2]
Summary
This document notes a Phase 1/Phase 2 clinical trial evaluating ephedrine for the treatment of congenital myasthenic syndromes.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hadassah Medical Organization | Conditions: Myasthenic Syndromes, Congenital | Phase 1, Phase 2 | Status: UNKNOWN